Table: begin end state 1 30 cytoplasmic 31 50 transmembrane 51 55 non-cytoplasmic 56 80 transmembrane 81 89 cytoplasmic 90 111 transmembrane 112 116 non-cytoplasmic 117 145 transmembrane 146 161 cytoplasmic 162 179 transmembrane 180 189 non-cytoplasmic 190 210 transmembrane 211 230 cytoplasmic 231 259 transmembrane 260 277 non-cytoplasmic 278 296 transmembrane 297 307 cytoplasmic 308 327 transmembrane 328 333 non-cytoplasmic 334 358 transmembrane 359 370 cytoplasmic 371 394 transmembrane 395 403 non-cytoplasmic 404 422 transmembrane 423 434 cytoplasmic
Input: >AO353_26710 MQATTHPPATSARSKVSAIFRVTSGNFLEQFDFFLFGFYATYIAAAFFPASSEFASLMMT FAVFGAGFLMRPLGAVILGAYIDDVGRRKGLIVTLSIMASGTILIVLVPGYETIGLFAPA LVLIGRLLQGFSAGAELGGVSVYLAEIATPGRKGFFTSWQSASQQVAIVVAAALGYALNQ WMPATVVADWGWRIPFFVGCMIVPFIFLLRRSLEETAEFTARRHRPSMRQVFGTLLQNWQ IVIAGMLMVALTTTAFYLITVYAPTFGKTVLHLSTSDALLVTLLVGVSNFCWLPLGGALS DRIGRRPVLVAMTLLTLATAYPALTYLVQAPSFINMLLVLLWLSFIYGLYNGAMVAALTE IMPVEVRVAGFSLAYSLATAVFGGFTPAISTFLIQYSGDKAAPGYWMSFAALCALCATLY LYRRSTGRLQVAVQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server